PUBLISHER: 360iResearch | PRODUCT CODE: 2143475

PUBLISHER: 360iResearch | PRODUCT CODE: 2143475

Blood Collection Needle-Pen Type Market - Global Forecast 2026-2032

PUBLISHED: October 7, 2026

PAGES: 188 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The Blood Collection Needle-Pen Type Market is projected to grow by USD 19.23 billion at a CAGR of 8.10% by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 11.14 billion
Estimated Year [2026]	USD 11.86 billion
Forecast Year [2032]	USD 19.23 billion
CAGR (%)	8.10%

Blood Collection Needle-Pen Type: Executive Overview

Blood collection needle-pen type products support venous and capillary blood sampling across hospitals, diagnostic laboratories, outpatient facilities, and decentralized testing environments. Product selection is shaped by patient safety, collection accuracy, operator ergonomics, compatibility with tubes and collection systems, and requirements for infection prevention. Demand conditions vary according to healthcare access, diagnostic activity, reimbursement structures, procurement standards, and the pace of laboratory modernization.

Safety, Workflow, and Sustainability Are Reshaping Needle-Pen Design

The landscape is shifting toward devices that reduce needlestick exposure, simplify handling, and improve consistency during collection. Safety-engineered features, protective mechanisms, clear labeling, ergonomic grips, and compatibility with established blood-collection workflows are increasingly important in procurement decisions. Facilities are also paying closer attention to packaging efficiency, material use, waste segregation, and dependable supply continuity. Regulatory compliance and validated performance remain essential as healthcare providers balance staff protection, patient comfort, and operational efficiency.

Artificial Intelligence Improves Quality Control and Supply Decisions

Artificial intelligence is contributing indirectly to this market through demand planning, inventory optimization, quality inspection, and workflow analytics. Computer-vision systems can support manufacturing checks for dimensions, assembly, labeling, and packaging integrity, while predictive tools can help healthcare networks identify replenishment needs and reduce stockout risk. AI-enabled laboratory and hospital systems may also improve procedure documentation and traceability. Adoption remains dependent on data quality, cybersecurity, validation, interoperability, and human oversight; AI does not replace clinical or regulatory responsibility for device selection and use.

Regional Insights: Regulation and Care Access Shape Adoption

North America emphasizes occupational safety, standardized procurement, and advanced healthcare workflows. Europe places strong weight on conformity assessment, traceability, sustainability, and coordinated quality requirements, while the Middle East is influenced by centralized purchasing, hospital investment, and import considerations. Asia-Pacific combines sophisticated healthcare systems with rapidly expanding diagnostic access and varied regulatory environments. Latin America is shaped by public procurement, private laboratory growth, affordability, and distribution reliability. Africa presents diverse conditions in which essential diagnostics, workforce training, infrastructure, and resilient supply chains are particularly important. Across all regions, adoption depends on balancing safety features and performance with usability and total cost of ownership.

Group Insights: Regional Blocs Create Distinct Procurement Priorities

ASEAN markets generally require adaptable distribution and regulatory strategies because healthcare capacity and approval processes differ among members. BRICS participants combine large and diverse healthcare systems with strong interest in local manufacturing, procurement resilience, and broader diagnostic access. The European Union benefits from coordinated regulatory principles while retaining national differences in purchasing and clinical practice. G7 settings typically prioritize advanced safety engineering, evidence-based procurement, and sustainability expectations. GCC countries often emphasize centralized healthcare programs, imported technologies, and high service reliability. NATO members may place additional importance on supply continuity, standardized emergency readiness, and secure medical-device logistics.

Country Insights: Diverse Health Systems Require Localized Execution

Australia and Canada emphasize quality assurance, geographically resilient distribution, and integration across centralized and regional care. Brazil and Mexico combine public-sector procurement with substantial private diagnostic activity and require attention to affordability and local supply conditions. China and India present broad healthcare diversity, domestic manufacturing potential, and substantial variation between urban and rural access. Japan and South Korea prioritize precision, reliability, workforce efficiency, and mature clinical workflows. France, Germany, Italy, Spain, and the United Kingdom are shaped by rigorous regulation, institutional procurement, and sustainability considerations, with differences in reimbursement and purchasing structures. Russia requires careful attention to regulatory, logistical, and supply-chain conditions. The United States places strong emphasis on needlestick prevention, product validation, institutional contracting, and operational standardization.

Action Priorities for Leaders in Blood Collection Devices

Industry leaders should design portfolios around validated safety performance, intuitive handling, and compatibility with common collection workflows rather than relying on a single product configuration. They should maintain region-specific regulatory plans, qualify multiple supply sources, and use demand analytics to protect continuity for hospitals and laboratories. Evidence packages should address user safety, patient experience, packaging integrity, sterilization, and disposal requirements. Partnerships with distributors and healthcare systems can improve training and feedback, while responsible AI deployment should focus on auditable quality control and inventory support. Sustainability efforts should be measurable and aligned with local waste-management capabilities.

Research Methodology: Evidence-Based Assessment of Product and Operating Conditions

This executive summary uses a structured qualitative assessment of blood collection needle-pen type products, focusing on clinical use cases, safety engineering, procurement criteria, regulatory conditions, healthcare infrastructure, distribution requirements, and technology adoption. The analysis compares the specified regions, groups, and countries through documented healthcare-system characteristics and device-management priorities. It excludes market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims. Interpretations should be validated against current national regulations, facility-level procurement policies, product instructions for use, and applicable clinical evidence before operational decisions are made.

Conclusion: Reliable, Safe Collection Supports Diagnostic System Performance

Blood collection needle-pen type products remain closely tied to the safety and efficiency of routine diagnostics. Competitive differentiation is increasingly determined by dependable performance, ergonomic design, compliance, workflow fit, supply resilience, and responsible environmental management. Regional and country conditions require localized execution, while AI can strengthen quality and planning when governed appropriately. Leaders that combine evidence-based product development with disciplined regulatory, training, and supply-chain practices will be better positioned to support safer and more consistent blood collection.

Product Code: MRR-9C4233EE7CEA

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Blood Collection Needle-Pen Type Market, by Device Type

7.1. Introduction
7.2. Automatic
- 7.2.1. Electronic Mechanism
- 7.2.2. Spring Mechanism
7.3. Manual
- 7.3.1. Button Release
- 7.3.2. Capillary Activation

8. Blood Collection Needle-Pen Type Market, by Needle Gauge

8.1. Introduction
8.2. 28G
8.3. 30G
8.4. 31G
8.5. 32G

9. Blood Collection Needle-Pen Type Market, by Material

9.1. Introduction
9.2. Polymer
9.3. Stainless Steel

10. Blood Collection Needle-Pen Type Market, by Packaging

10.1. Introduction
10.2. Bulk
10.3. Sterile Individual

11. Blood Collection Needle-Pen Type Market, by Application

11.1. Introduction
11.2. Blood Glucose Monitoring
11.3. Blood Sample Collection

12. Blood Collection Needle-Pen Type Market, by End User

12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Diagnostic Centers
12.4. Home Care
12.5. Hospitals

13. Blood Collection Needle-Pen Type Market, by Distribution Channel

13.1. Introduction
13.2. Direct Tender
13.3. Hospital Pharmacies
13.4. Online Stores
13.5. Retail Pharmacies

14. Blood Collection Needle-Pen Type Market, by Region

14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa

15. Blood Collection Needle-Pen Type Market, by Group

15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO

16. Blood Collection Needle-Pen Type Market, by Country

16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea

17. Competitive Landscape

17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
- 17.2.1. Concentration Ratio (CR)
- 17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025

18. Company Profiles

18.1. ARKRAY, Inc.
18.2. Becton, Dickinson and Company
18.3. F. Hoffmann-La Roche Ltd.
18.4. Gerresheimer AG
18.5. Greiner Bio-One International GmbH
18.6. HTL-STREFA
18.7. Jiangsu Yuyue Medical Instruments & Equipment Co., Ltd.
18.8. Nipro Corporation
18.9. Owen Mumford Inc.
18.10. Owen Mumford Ltd.
18.11. Sarstedt AG & Co. KG
18.12. Terumo Corporation
18.13. Vygon S.A.

19. Key Experts